BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:6041-6047. [PMID: 18023097 DOI: 10.3748/wjg.v13.45.6041] [Cited by in Crossref: 26] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bashashati M, Moossavi S, Cremon C, Barbaro MR, Moraveji S, Talmon G, Rezaei N, Hughes PA, Bian ZX, Choi CH, Lee OY, Coëffier M, Chang L, Ohman L, Schmulson MJ, Mccallum RW, Simren M, Sharkey KA, Barbara G. Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil 2018;30:e13192. [DOI: 10.1111/nmo.13192] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 13.5] [Reference Citation Analysis]
2 Lee KN, Lee OY. The Role of Mast Cells in Irritable Bowel Syndrome. Gastroenterol Res Pract. 2016;2016:2031480. [PMID: 28115927 DOI: 10.1155/2016/2031480] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
3 Robles A, Perez Ingles D, Myneedu K, Deoker A, Sarosiek I, Zuckerman MJ, Schmulson MJ, Bashashati M. Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil 2019;31:e13718. [PMID: 31498961 DOI: 10.1111/nmo.13718] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
4 Bian ZX, Zhang M, Han QB, Xu HX, Sung JJ. Analgesic effects of JCM-16021 on neonatal maternal separation-induced visceral pain in rats. World J Gastroenterol 2010; 16(7): 837-845 [PMID: 20143462 DOI: 10.3748/wjg.v16.i7.837] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
5 El-Salhy M, Gilja OH, Hausken T. Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome. Mol Med Rep. 2014;10:1753-1757. [PMID: 25109259 DOI: 10.3892/mmr.2014.2472] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
6 Gu HX, Zhang YL, Zhi FC, Jiang B, Huang Y. Organic colonic lesions in 3,332 patients with suspected irritable bowel syndrome and lacking warning signs, a retrospective case--control study. Int J Colorectal Dis 2011;26:935-40. [PMID: 21374060 DOI: 10.1007/s00384-011-1163-2] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
7 El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG, Hausken T. Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review). Int J Mol Med 2014;34:363-71. [PMID: 24939595 DOI: 10.3892/ijmm.2014.1811] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
8 Wang XJ, Carlson P, Chedid V, Maselli DB, Taylor AL, McKinzie S, Camilleri M. Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome. Clin Transl Gastroenterol 2021;12:e00329. [PMID: 33843785 DOI: 10.14309/ctg.0000000000000329] [Reference Citation Analysis]
9 Mazzawi T, El-Salhy M. Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome. Exp Ther Med. 2016;12:1398-1404. [PMID: 27588061 DOI: 10.3892/etm.2016.3491] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
10 El-Salhy M, Gilja OH. Abnormalities in ileal stem, neurogenin 3, and enteroendocrine cells in patients with irritable bowel syndrome. BMC Gastroenterol 2017;17:90. [PMID: 28764761 DOI: 10.1186/s12876-017-0643-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
11 Aich A, Afrin LB, Gupta K. Mast Cell-Mediated Mechanisms of Nociception. Int J Mol Sci 2015;16:29069-92. [PMID: 26690128 DOI: 10.3390/ijms161226151] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 11.5] [Reference Citation Analysis]
12 Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, Rossi F, Lo Monte AI, Rizzo AG, Raimondo D. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol 2016; 22(7): 2242-2255 [PMID: 26900287 DOI: 10.3748/wjg.v22.i7.2242] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 47] [Article Influence: 10.8] [Reference Citation Analysis]
13 Hamilton MJ, Hornick JL, Akin C, Castells MC, Greenberger NJ. Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol 2011;128:147-152.e2. [PMID: 21621255 DOI: 10.1016/j.jaci.2011.04.037] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 7.8] [Reference Citation Analysis]
14 Serra-Campos AO, Abreu-Junior ANG, Nascimento AA, Abidu-Figueiredo M, Lima MSCS, Machado-Santos C. Gastroesophageal tube of the Iguana iguana (Iguanidae): histological description, histochemical and immunohistochemical analysis of 5-HT and SS cells. Braz J Biol 2021;83:e242086. [PMID: 34161453 DOI: 10.1590/1519-6984.242086] [Reference Citation Analysis]
15 El-Salhy M, Vaali K, Dizdar V, Hausken T. Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Dig Dis Sci. 2010;55:3508-3513. [PMID: 20300845 DOI: 10.1007/s10620-010-1169-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
16 Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012;18:258-268. [PMID: 22837873 DOI: 10.5056/jnm.2012.18.3.258] [Cited by in Crossref: 98] [Cited by in F6Publishing: 91] [Article Influence: 10.9] [Reference Citation Analysis]
17 El-Salhy M, Gundersen D, Gilja OH, Hatlebakk JG, Hausken T. Is irritable bowel syndrome an organic disorder? World J Gastroenterol 2014; 20(2): 384-400 [PMID: 24574708 DOI: 10.3748/wjg.v20.i2.384] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 9.3] [Reference Citation Analysis]
18 El-Salhy M. Irritable bowel syndrome: Diagnosis and pathogenesis. World J Gastroenterol 2012; 18(37): 5151-5163 [PMID: 23066308 DOI: 10.3748/wjg.v18.i37.5151] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 98] [Article Influence: 7.3] [Reference Citation Analysis]
19 Shi HL, Liu CH, Ding LL, Zheng Y, Fei XY, Lu L, Zhou XM, Yuan JY, Xie JQ. Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction. World J Gastroenterol 2015; 21(16): 4852-4863 [PMID: 25944998 DOI: 10.3748/wjg.v21.i16.4852] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
20 El-Salhy M. Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2020; 26(13): 1427-1438 [PMID: 32308344 DOI: 10.3748/wjg.v26.i13.1427] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Zare-Mirzaie A, Lotfi M, Sadeghipour A, Haghi-Ashtiani MT. Analysis of colonic mucosa mast cell count in patients with chronic diarrhea. Saudi J Gastroenterol. 2012;18:322-326. [PMID: 23006460 DOI: 10.4103/1319-3767.101128] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Zhong L, Hou X. Pathophysiologic findings of irritable bowel syndrome in china. J Neurogastroenterol Motil. 2012;18:19-33. [PMID: 22323985 DOI: 10.5056/jnm.2012.18.1.19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
23 El-Salhy M, Gundersen D, Ostgaard H, Lomholt-Beck B, Hatlebakk JG, Hausken T. Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome. Dig Dis Sci. 2012;57:873-878. [PMID: 22057239 DOI: 10.1007/s10620-011-1948-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
24 Burns G, Carroll G, Mathe A, Horvat J, Foster P, Walker MM, Talley NJ, Keely S. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review. Am J Gastroenterol. 2019;114:429-436. [PMID: 30839392 DOI: 10.1038/s41395-018-0377-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 21.5] [Reference Citation Analysis]
25 Bennet SM, Ohman L, Simren M. Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver. 2015;9:318-331. [PMID: 25918261 DOI: 10.5009/gnl14344] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 15.6] [Reference Citation Analysis]
26 Luo M, Zhuang X, Tian Z, Xiong L. Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis. BMC Gastroenterol 2021;21:14. [PMID: 33407171 DOI: 10.1186/s12876-020-01577-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 El-Salhy M, Hatlebakk JG, Hausken T. Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. World J Gastroenterol 2015; 21(32): 9577-9587 [PMID: 26327765 DOI: 10.3748/wjg.v21.i32.9577] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
28 Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes 2009;16:53-9. [PMID: 19115522 DOI: 10.1097/med.0b013e32831e9c8e] [Cited by in Crossref: 83] [Cited by in F6Publishing: 32] [Article Influence: 6.9] [Reference Citation Analysis]
29 El-Salhy M, Gilja OH, Gundersen D, Hausken T. Endocrine cells in the oxyntic mucosa of the stomach in patients with irritable bowel syndrome. World J Gastrointest Endosc 2014; 6(5): 176-185 [PMID: 24891930 DOI: 10.4253/wjge.v6.i5.176] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
30 Valdez-Morales EE, Overington J, Guerrero-Alba R, Ochoa-Cortes F, Ibeakanma CO, Spreadbury I, Bunnett NW, Beyak M, Vanner SJ. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2. Am J Gastroenterol. 2013;108:1634-1643. [PMID: 23958521 DOI: 10.1038/ajg.2013.241] [Cited by in Crossref: 69] [Cited by in F6Publishing: 69] [Article Influence: 8.6] [Reference Citation Analysis]
31 Kajander K, Myllyluoma E, Kyrönpalo S, Rasmussen M, Sipponen P, Mattila I, Seppänen-Laakso T, Vapaatalo H, Orešič M, Korpela R. Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome. World J Gastroenterol 2009; 15(48): 6068-6074 [PMID: 20027679 DOI: 10.3748/wjg.15.6068] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
32 Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012;18:258-268. [PMID: 22837873 DOI: 10.5056/jnm.2012. 18.3.258] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG, Hausken T. Endocrine cells in the ileum of patients with irritable bowel syndrome. World J Gastroenterol 2014; 20(9): 2383-2391 [PMID: 24605036 DOI: 10.3748/wjg.v20.i9.2383] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
34 Braak B, Klooker TK, Wouters MM, Welting O, van der Loos CM, Stanisor OI, van Diest S, van den Wijngaard RM, Boeckxstaens GE. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship? Am J Gastroenterol. 2012;107:715-726. [PMID: 22488080 DOI: 10.1038/ajg.2012.54] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
35 Mohammadian G, Dlugosz A, Shetye J, Lindberg G. Quantification of mucosal EEC in jejunum. A comparative study of IBS patients and healthy controls. Scand J Gastroenterol 2020;55:543-8. [PMID: 32442056 DOI: 10.1080/00365521.2020.1764615] [Reference Citation Analysis]
36 Boyer J, Saint-paul M, Dadone B, Patouraux S, Vivinus M, Ouvrier D, Michiels J, Piche T, Tulic MK. Inflammatory cell distribution in colon mucosa as a new tool for diagnosis of irritable bowel syndrome: A promising pilot study. Neurogastroenterol Motil 2018;30:e13223. [DOI: 10.1111/nmo.13223] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
37 Mansueto P, D’Alcamo A, Seidita A, Carroccio A. Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity. World J Gastroenterol 2015; 21(23): 7089-7109 [PMID: 26109796 DOI: 10.3748/wjg.v21.i23.7089] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
38 Medland JE, Pohl CS, Edwards LL, Frandsen S, Bagley K, Li Y, Moeser AJ. Early life adversity in piglets induces long-term upregulation of the enteric cholinergic nervous system and heightened, sex-specific secretomotor neuron responses. Neurogastroenterol Motil 2016;28:1317-29. [PMID: 27134125 DOI: 10.1111/nmo.12828] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
39 Albert-Bayo M, Paracuellos I, González-Castro AM, Rodríguez-Urrutia A, Rodríguez-Lagunas MJ, Alonso-Cotoner C, Santos J, Vicario M. Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis. Cells 2019;8:E135. [PMID: 30744042 DOI: 10.3390/cells8020135] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 26.0] [Reference Citation Analysis]
40 El-Salhy M, Gilja OH, Hatlebakk JG, Hausken T. Stomach antral endocrine cells in patients with irritable bowel syndrome. Int J Mol Med. 2014;34:967-974. [PMID: 25110039 DOI: 10.3892/ijmm.2014.1887] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
41 Chang L, Adeyemo M, Karagiannides I, Videlock EJ, Bowe C, Shih W, Presson AP, Yuan PQ, Cortina G, Gong H. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol. 2012;107:262-272. [PMID: 22158028 DOI: 10.1038/ajg.2011.423] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 9.8] [Reference Citation Analysis]
42 Miura K, Oshima T, Ito C, Horikawa T, Yamada M, Tomita T, Fukui H, Miwa H. Vitamin D receptor is overexpressed in the duodenum of patients with irritable bowel syndrome. J Gastroenterol Hepatol 2021;36:951-8. [PMID: 32839988 DOI: 10.1111/jgh.15225] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 El-Salhy M, Gundersen D. Diet in irritable bowel syndrome. Nutr J. 2015;14:36. [PMID: 25880820 DOI: 10.1186/s12937-015-0022-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
44 Lazaridis N, Germanidis G. Current insights into the innate immune system dysfunction in irritable bowel syndrome. Ann Gastroenterol 2018;31:171-87. [PMID: 29507464 DOI: 10.20524/aog.2018.0229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
45 El-Salhy M. Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2015; 21(25): 7621-7636 [PMID: 26167065 DOI: 10.3748/wjg.v21.i25.7621] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 52] [Article Influence: 9.3] [Reference Citation Analysis]